JMI LABS IS NOW PART OF LEARN MORE

Preliminary Microbiology Results from a Phase III Omiganan Pentahydrochloride Clinical Trial: In Vitro Activity Against Bacterial and Fungal Pathogens, Lead author: Fritsche TR, presented at 18th annual Society for Healthcare Epidemiology of America, April 5 – 8, 2008, Orlando, FL

View publication